Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1

Author(s):  Allen Loyd V Jr

Issue:  Mar/Apr 2017 - Volume 21, Number 2
View All Articles in Issue

Page(s):  127-130

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Page 1
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Page 2
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Page 3
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Page 4

Download in electronic PDF format for $75

Abstract:  Three-dimensional printing quickly became a standard tool in the automotive, aerospace, and consumer goods industries and, recently, has begun gaining traction in pharmaceutical manufacturing. 3D printing has steadily grown, introducing a new element into dosage form development, and has received a boost with U.S. Food and Drug Administration (FDA) approval of the 3D-printed orodispersible tablet, Spritam (levetiracetam). This part 1 of a 3-part article introduces 3D printing and its application to pharmacy.

Related Keywords: Loyd V. Allen, Jr., PhD, RPh, 3D printing, pharmaceutical manufacturing, dosage form development, U.S. Food and Drug Administration, FDA, orodispersible tablet, levetiracetam, complex dosage forms, personalization, on-demand compounding, delayed release, transdermal administration, long-acting implants, modified release, multiple release, combination drug products, customized dosage forms, decentralization, decentralized manufacturing, additive manufacturing, stereolithography file format, .stl, rapid disintegration, low-stability drugs

Related Categories: LEGAL, TECHNOLOGY, DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1
Allen Loyd V Jr
Mar/Apr 2017
Pg. 127-130

Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2
Allen Loyd V Jr
May/Jun 2017
Pg. 215-220

Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing
Allen Loyd V Jr
Sep/Oct 2017
Pg. 388-392

Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future
Allen Loyd V Jr
Jul/Aug 2017
Pg. 293-298

Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Kumaravelrajan Rajagopal
, Karthik B, Venkatasan Suba
Nov/Dec 2022
Pg. 516-521

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients
Allen Loyd V Jr
Nov/Dec 2023
Pg. 474-481

Molding as Innovative Technology for Personalized Tablet Production
Mady Omar Y
, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Mar/Apr 2022
Pg. 163-174

Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
Jan/Feb 2017
Pg. 47-56

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

Basics of Compounding: Foam Dosage Forms
Allen Loyd V Jr
Jul/Aug 2013
Pg. 312-322

Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
Sep/Oct 2015
Pg. 389-390

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Timko Robert J
, Crooker Philip EM
Mar/Apr 2014
Pg. 101-111

Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
Nov/Dec 2014
Pg. 479-484

U.S. Food and Drug Administration Inspection Authority: How to Know Whether U.S. Food and Drug Administration Inspectors Are Crossing the Line
Snow Stephen T
, Stannard Robert W, Bellis Jennifer, Moss Carrie A
Jan/Feb 2019
Pg. 32-33

Return to Top